Biliary Tract Carcinoma — Trials

Biliary Tract Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 238
Recruiting: 138
Ph III recruiting: 9
Growth YoY: +12.7%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (111)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02027311	Etomidate vs. Midazolam for Sedation During ERCP	completed	Phase 4	63	Cheju Halla General HospitalOTHER	1	Jun 29, 2015	clinicaltrials
NCT00721175	Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma	completed	Phase 4	108	Khon Kaen UniversityOTHER	1	Dec 23, 2011	clinicaltrials
NCT00168987